- Company Overview for INGENOX THERAPEUTICS LIMITED (14127227)
- Filing history for INGENOX THERAPEUTICS LIMITED (14127227)
- People for INGENOX THERAPEUTICS LIMITED (14127227)
- Registers for INGENOX THERAPEUTICS LIMITED (14127227)
- More for INGENOX THERAPEUTICS LIMITED (14127227)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
19 Sep 2024 | TM01 | Termination of appointment of William John Robert Fleming as a director on 18 September 2024 | |
03 Jul 2024 | AA01 | Current accounting period extended from 30 June 2024 to 31 December 2024 | |
29 May 2024 | CS01 | Confirmation statement made on 23 May 2024 with updates | |
24 May 2024 | AD03 | Register(s) moved to registered inspection location 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT | |
24 May 2024 | AD02 | Register inspection address has been changed to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT | |
24 Apr 2024 | TM01 | Termination of appointment of Nicholas George Dixon-Clegg as a director on 19 April 2024 | |
24 Apr 2024 | TM01 | Termination of appointment of Simon Kerry as a director on 19 April 2024 | |
24 Apr 2024 | AP01 | Appointment of Sandip Bobby Reddy as a director on 19 April 2024 | |
24 Apr 2024 | TM01 | Termination of appointment of James Julian Noble as a director on 19 April 2024 | |
24 Apr 2024 | AP01 | Appointment of Leonard S. Sender as a director on 19 April 2024 | |
24 Apr 2024 | AP01 | Appointment of Patrick Soon-Shiong as a director on 19 April 2024 | |
24 Apr 2024 | PSC01 | Notification of Patrick Soon-Shiong as a person with significant control on 19 April 2024 | |
24 Apr 2024 | PSC09 | Withdrawal of a person with significant control statement on 24 April 2024 | |
01 Mar 2024 | SH01 |
Statement of capital following an allotment of shares on 1 March 2024
|
|
27 Oct 2023 | SH01 |
Statement of capital following an allotment of shares on 19 October 2023
|
|
26 Sep 2023 | AA | Total exemption full accounts made up to 30 June 2023 | |
11 Sep 2023 | TM01 | Termination of appointment of Richard Kirby Taylor as a director on 17 August 2023 | |
21 Jun 2023 | CS01 | Confirmation statement made on 23 May 2023 with updates | |
15 Mar 2023 | RESOLUTIONS |
Resolutions
|
|
10 Mar 2023 | SH01 |
Statement of capital following an allotment of shares on 8 March 2023
|
|
28 Feb 2023 | AA01 | Current accounting period extended from 31 May 2023 to 30 June 2023 | |
26 Jan 2023 | CERTNM |
Company name changed celleron therapeutics holdings LIMITED\certificate issued on 26/01/23
|
|
24 Jan 2023 | AP01 | Appointment of James Julian Noble as a director on 22 December 2022 | |
24 Jan 2023 | AP01 | Appointment of Richard Kirby Taylor as a director on 22 December 2022 | |
17 Jan 2023 | PSC08 | Notification of a person with significant control statement |